Balancing Innovation and Access: Insights from AIM’s Fair Pricing Model and Its Current and Future Applications
PharmacoEconomics · 2026-08 · 44 (8) · 949-962
DOI: 10.1007/s40273-026-01615-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift PharmacoEconomics, online erschienen am 16.04.2026. Verfasst von Jocelijn Stokx und 10 weiteren Autor:innen. Beteiligte Einrichtung: CM Health Insurance Fund, Brussels, Belgium. Hauptthemen laut MEDLINE: Drug Costs, Health Services Accessibility, Models, Economic. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- CM Health Insurance Fund, Brussels, Belgium.
- Solidaris Health Insurance Fund, Brussels, Belgium.
- Estonian Health Insurance Fund, Tervisekassa, Tallinn, Estonia.
- Zorgverzekeraars Nederland, Zeist, The Netherlands.
- Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
- Techniker Krankenkasse, Hamburg, Germany.
Zitieren
APA
Stokx, J., Hendrickx, A., Veliste, K., Brouns, C., Scheffler, S., Schoch, G. G., Slapsak, M., Macken, E., Walter, P., Kanga-Tona, T., & Barjesteh van Waalwijk van Doorn-Khosrovani, S. (2026). Balancing Innovation and Access: Insights from AIM’s Fair Pricing Model and Its Current and Future Applications. PharmacoEconomics, 44(8), 949-962. https://doi.org/10.1007/s40273-026-01615-2
Vancouver
Stokx J, Hendrickx A, Veliste K, Brouns C, Scheffler S, Schoch GG, et al. Balancing Innovation and Access: Insights from AIM’s Fair Pricing Model and Its Current and Future Applications. PharmacoEconomics. 2026;44(8):949-962. doi:10.1007/s40273-026-01615-2
BibTeX
@article{Stokx2026,
author = {Stokx, Jocelijn and Hendrickx, Anne and Veliste, Kärt and Brouns, Chiara and Scheffler, Sandra and Schoch, Goentje-Gesine and Slapsak, Maja and Macken, Evelyn and Walter, Patrick and Kanga-Tona, Thomas and Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar},
title = {Balancing Innovation and Access: Insights from AIM’s Fair Pricing Model and Its Current and Future Applications},
journal = {PharmacoEconomics},
year = {2026},
volume = {44},
number = {8},
pages = {949--962},
doi = {10.1007/s40273-026-01615-2}
}
EUVIMED